Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dill

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACENan Wei, René Michael Mathy, De-Hua Chang, et al.
Hepatology (Baltimore, Md.)|July 23, 2013
Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cellsAnne Frentzen, Anggakusuma, Engin Gürlevik, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective studyDaniel Hornuss, Anna Rudi, Lucas Koerner, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A proteaseKenichi Morikawa, Jérôme Gouttenoire, Céline Hernandez, et al.
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|August 19, 2022
Precision oncology for intrahepatic cholangiocarcinoma in clinical practiceAurelie Tomczak, Christoph Springfeld, Michael T Dill, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2025
Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACENan Wei, René Michael Mathy, De-Hua Chang, et al.
Hepatology (Baltimore, Md.)|July 23, 2013
Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cellsAnne Frentzen, Anggakusuma, Engin Gürlevik, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Clinics and Research in Hepatology and Gastroenterology|March 19, 2021
HBV-infection rate and long-term outcome after liver-transplantation of anti-HBc-positive liver-grafts to HBV-naïve recipients: A retrospective studyDaniel Hornuss, Anna Rudi, Lucas Koerner, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A proteaseKenichi Morikawa, Jérôme Gouttenoire, Céline Hernandez, et al.
The Journal of Clinical Investigation|February 27, 2014
Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationMichael T Dill, Zuzanna Makowska, Gaia Trincucci, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 24, 2014
An intrahepatic transcriptional signature of enhanced immune activity predicts response to peginterferon in chronic hepatitis BLouis Jansen, Annikki de Niet, Zuzanna Makowska, et al.
Pageof 8